| Morgan, Franklin |
| Completed | 3 | 1570 | Europe, Canada, US, RoW | Estetrol, Placebo, Progesterone | Estetra, ICON Clinical Research | Vasomotor Symptoms, Menopausal Symptoms | 02/24 | 02/24 | | |
| Recruiting | 3 | 160 | US | CCT-102 A and CCT-102 B | Conceptra Biosciences, LLC | Early Pregnancy Loss, Delayed Pregnancy Loss | 12/24 | 12/24 | | |
NCT05101317: A Study to Assess the Efficacy and Safety of HMI-115 in Subjects with Endometriosis-Associated Pain |
|
|
| Recruiting | 2 | 152 | Europe, US, RoW | HMI-115, Placebo | Hope Medicine (Nanjing) Co., Ltd | Endometriosis | 12/24 | 04/25 | | |
| Parva, Mehdi |
ZIMS, NCT05570916: Zip-Stitch® in Minimally-Invasive Surgery () - Safety & Efficacy in Hysterectomy |
|
|
| Active, not recruiting | N/A | 59 | US | Zip-stitch(R), Reference suture, V-Loc or VICRYL sutures | ZSX Medical LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Laparoscopic Hysterectomy | 06/24 | 05/25 | | |
| Rusch, April |
NCT05139121: Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles |
|
|
| Completed | 3 | 1319 | Canada, US | MR-100A-01, Transdermal contraceptive delivery system | Mylan Technologies Inc., Mylan Inc. | Contraception | 01/25 | 01/25 | | |
| Recruiting | 3 | 160 | US | CCT-102 A and CCT-102 B | Conceptra Biosciences, LLC | Early Pregnancy Loss, Delayed Pregnancy Loss | 12/24 | 12/24 | | |
NCT03942419: Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression |
|
|
| Terminated | 3 | 438 | US | Atropine 0.1% Ophthalmic Solution, Atropine 0.01% Ophthalmic Solution, Placebo Ophthalmic Solution | Eyenovia Inc. | Myopia | 10/24 | 11/24 | | |
NCT05096065: Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis |
|
|
| Recruiting | 2 | 16 | US | Leuprolide Oral Tablet - 120 mg - QD- Treatment A, Ovarest® 60 mg, Leuprolide Oral Tablet - 80 mg - QD - Treatment B, Ovarest® 40 mg, Leuprolide Oral Tablet - 60 mg - QD - Treatment C, Leuprolide Oral Tablet - 60 mg - BID - Treatment D, Leuprolide Oral Tablet - 40 mg - BID - Treatment E | Enteris BioPharma Inc., Parexel, Syneos Health | Endometriosis | 05/22 | 05/22 | | |
ELENA, NCT05560646: A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain |
|
|
| Active, not recruiting | 2 | 380 | Europe, US, RoW | OG-6219, Placebo | Organon and Co, Iqvia Pty Ltd | Endometriosis | 05/25 | 05/25 | | |
ZIMS, NCT05570916: Zip-Stitch® in Minimally-Invasive Surgery () - Safety & Efficacy in Hysterectomy |
|
|
| Active, not recruiting | N/A | 59 | US | Zip-stitch(R), Reference suture, V-Loc or VICRYL sutures | ZSX Medical LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Laparoscopic Hysterectomy | 06/24 | 05/25 | | |
| Holtz, David O |
HOTT, NCT05659381: Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer |
|
|
| Recruiting | 3 | 230 | US | Cisplatin, Platinol AQ, No treatment | GOG Foundation, GlaxoSmithKline | Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer, Stage IV Primary Peritoneal Cancer, Stage III Fallopian Tube Cancer, Stage IV Fallopian Tube Cancer | 08/29 | 08/34 | | |
ZIMS, NCT05570916: Zip-Stitch® in Minimally-Invasive Surgery () - Safety & Efficacy in Hysterectomy |
|
|
| Active, not recruiting | N/A | 59 | US | Zip-stitch(R), Reference suture, V-Loc or VICRYL sutures | ZSX Medical LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Laparoscopic Hysterectomy | 06/24 | 05/25 | | |
| Parva, Mohamad-Mehdi |
NCT05264506: Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive |
|
|
| Terminated | 3 | 2007 | US | NOMAC-E2 COC, Nomegestrol acetate / estradiol | Organon and Co, IQVIA Inc., OSTAtistics | Contraception | 01/24 | 01/24 | | |
ELENA, NCT05560646: A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain |
|
|
| Active, not recruiting | 2 | 380 | Europe, US, RoW | OG-6219, Placebo | Organon and Co, Iqvia Pty Ltd | Endometriosis | 05/25 | 05/25 | | |
| Parker, Lamar |
NCT05461573: Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females |
|
|
| Active, not recruiting | 3 | 1009 | US | Drospirenone, LPRI-CF113 | Insud Pharma, Chemo Research | Contraception, Change in Bone Mineral Density | 05/24 | 05/25 | | |
ZIMS, NCT05570916: Zip-Stitch® in Minimally-Invasive Surgery () - Safety & Efficacy in Hysterectomy |
|
|
| Active, not recruiting | N/A | 59 | US | Zip-stitch(R), Reference suture, V-Loc or VICRYL sutures | ZSX Medical LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Laparoscopic Hysterectomy | 06/24 | 05/25 | | |
